{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:42:19Z","timestamp":1768441339272,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00103-023-03694-4","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T09:02:54Z","timestamp":1681290174000},"page":"530-539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multimedikation in Einrichtungen der station\u00e4ren Langzeitpflege: M\u00f6glichkeiten einer Verbesserung der Arzneimitteltherapiesicherheit (AMTS)","Polypharmacy in nursing homes: options to improve drug therapy safety"],"prefix":"10.1007","volume":"66","author":[{"given":"Petra A.","family":"Th\u00fcrmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Bergner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Jaehde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"3694_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-3-662-66041-6_3","volume-title":"Arzneimittel-Kompass 2022","author":"M Van den Akker","year":"2022","unstructured":"Van den Akker\u00a0M, Harder\u00a0S, Dieckelmann\u00a0M, Muth\u00a0C (2022) Multimedikation. In: Schr\u00f6der\u00a0H, Th\u00fcrmann\u00a0P, Telschow\u00a0C, Schr\u00f6der\u00a0M, Busse\u00a0R (Hrsg) Arzneimittel-Kompass 2022. Springer, Berlin, Heidelberg, S 33\u201349 https:\/\/doi.org\/10.1007\/978-3-662-66041-6_3"},{"key":"3694_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-662-66041-6_4","volume-title":"Arzneimittel-Kompass 2022","author":"P Th\u00fcrmann","year":"2022","unstructured":"Th\u00fcrmann\u00a0P, Mann\u00a0NK, Zawinell\u00a0A, Niepraschk-von Dollen\u00a0K, Schr\u00f6der\u00a0H (2022) Potenziell inad\u00e4quate Medikation f\u00fcr \u00e4ltere Menschen \u2013 PRISCUS 2.0. In: Schr\u00f6der\u00a0H, Th\u00fcrmann\u00a0P, Telschow\u00a0C, Schr\u00f6der\u00a0M, Busse\u00a0R (Hrsg) Arzneimittel-Kompass 2022. Springer, Berlin, Heidelberg, S 51\u201376 https:\/\/doi.org\/10.1007\/978-3-662-66041-6_4"},{"key":"3694_CR3","first-page":"252","volume-title":"Pflege-Report 2022 Spezielle Versorgungslagen in der Langzeitpflege","author":"S Matzk","year":"2022","unstructured":"Matzk\u00a0S, Tsiasioti\u00a0C, Behrendt\u00a0S, J\u00fcrchott\u00a0K, Schwinger\u00a0A (2022) Pflegebedarf in Deutschland. In: Jacobs\u00a0K, Gre\u00df, Klauber, Schwinger (Hrsg) Pflege-Report 2022 Spezielle Versorgungslagen in der Langzeitpflege. Springer, Heidelberg, S 252\u2013286"},{"key":"3694_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-662-66041-6_5","volume-title":"Arzneimittel-Kompass 2022","author":"S Behrendt","year":"2022","unstructured":"Behrendt\u00a0S, Jaehde\u00a0U, \u00d6zdes\u00a0T, Schwinger\u00a0A (2022) Arzneimittelversorgung in Pflegeheimen. In: Schr\u00f6der\u00a0H, Th\u00fcrmann\u00a0P, Telschow\u00a0C, Schr\u00f6der\u00a0M, Busse\u00a0R (Hrsg) Arzneimittel-Kompass 2022. Springer, Berlin, Heidelberg, S 77\u201376 https:\/\/doi.org\/10.1007\/978-3-662-66041-6_5"},{"issue":"12","key":"3694_CR5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","volume":"17","author":"JW Wastesson","year":"2018","unstructured":"Wastesson\u00a0JW, Morin\u00a0L, Tan\u00a0ECK, Johnell\u00a0K (2018) An update on the clinical consequences of polypharmacy in older adults: a\u00a0narrative review. Expert Opin Drug Saf 17(12):1185\u20131196. https:\/\/doi.org\/10.1080\/14740338.2018.1546841","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"3694_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/14740338.2018.1415322","volume":"17","author":"S Schmiedl","year":"2018","unstructured":"German Net of Regional Pharmacovigilance Centers (NRPC), Schmiedl\u00a0S, Rottenkolber\u00a0M, Szymanski\u00a0J et al (2018) Preventable ADRs leading to hospitalization\u2014results of a\u00a0long-term prospective safety study with 6,427 ADR cases focusing on elderly patients. Expert Opin Drug Saf 17(2):125\u2013137","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"3694_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/17512433.2018.1528145","volume":"11","author":"SN Hilmer","year":"2018","unstructured":"Hilmer\u00a0SN (2018) Calculating and using the drug burden index score in research and practice. Expert Rev Clin Pharmacol 11(11):1053\u20131055. https:\/\/doi.org\/10.1080\/17512433.2018.1528145","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"3694_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12877-018-0929-6","volume":"18","author":"EK Kiesel","year":"2018","unstructured":"Kiesel\u00a0EK, Hopf\u00a0YM, Drey\u00a0M (2018) An anticholinergic burden score for German prescribers: score development. BMC Geriatr 18(1):239. https:\/\/doi.org\/10.1186\/s12877-018-0929-6","journal-title":"BMC Geriatr"},{"key":"3694_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neubiorev.2021.04.031","volume":"127","author":"YB Zheng","year":"2021","unstructured":"Zheng\u00a0YB, Shi\u00a0L, Zhu\u00a0XM et al (2021) Anticholinergic drugs and the risk of dementia: a systematic review and meta-analysis. Neurosci Biobehav Rev 127:296\u2013306. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.04.031","journal-title":"Neurosci Biobehav Rev"},{"key":"3694_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013540.pub2","author":"M Taylor-Rowan","year":"2021","unstructured":"Taylor-Rowan\u00a0M, Edwards\u00a0S, Noel-Storr\u00a0AH et al (2021) Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD013540.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3694_CR11","unstructured":"Th\u00fcrmann PA, Bencheva V, Gogolin M, Mann NK (2021) Polypharmazie im Alter \u2013 Die Kunst des Ma\u00dfhaltens. Niedergelassene Arzt (11):57\u201362"},{"key":"3694_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/pharma1010002","volume":"1","author":"V Lappe","year":"2022","unstructured":"Lappe\u00a0V, Dinh\u00a0TS, Harder\u00a0S et\u00a0al (2022) Multimedication Guidelines: Assessment of the Size of the Target Group for Medication Review and Description of the Frequency of Their Potential Drug Safety Problems with Routine Data. Pharmacoepidemiology 1:12\u201325. https:\/\/doi.org\/10.3390\/pharma1010002","journal-title":"Pharmacoepidemiology"},{"issue":"4","key":"3694_CR13","doi-asserted-by":"publisher","first-page":"371.e1","DOI":"10.1016\/j.jamda.2017.12.013","volume":"19","author":"M de Vries","year":"2018","unstructured":"de Vries\u00a0M, Seppala\u00a0LJ, Daams\u00a0JG, van de Glind\u00a0EMM, Masud\u00a0T, van der Velde\u00a0N, EUGMS Task and Finish Group on Fall-Risk-Increasing Drugs (2018) Fall-risk-increasing drugs: a systematic review and meta-analysis: I. Cardiovascular drugs. J\u00a0Am Med Dir Assoc 19(4):371.e1\u2013371.e9. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.013","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"3694_CR14","doi-asserted-by":"publisher","first-page":"372.e1","DOI":"10.1016\/j.jamda.2017.12.099","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"EUGMS Task and Finish Group on Fall-Risk-Increasing Drugs, Seppala\u00a0LJ, van de Glind\u00a0EMM, Daams\u00a0JG et al (2018) Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J\u00a0Am Med Dir Assoc 19(4):372.e1\u2013372.e8. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.099","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"3694_CR15","doi-asserted-by":"publisher","first-page":"371.e11","DOI":"10.1016\/j.jamda.2017.12.098","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"EUGMS task and Finish group on fall-risk-increasing drugs. Fall-Risk-Increasing Drugs, Seppala\u00a0LJ, Wermelink\u00a0AMAT, de Vries\u00a0M et al (2018) A systematic review and meta-analysis: II. psychotropics. J\u00a0Am Med Dir Assoc 19(4):371.e11\u2013371.e17. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.098","journal-title":"J Am Med Dir Assoc"},{"issue":"31\u201332","key":"3694_CR16","first-page":"543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt\u00a0S, Schmiedl\u00a0S, Th\u00fcrmann\u00a0PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107(31\u201332):543\u2013551","journal-title":"Dtsch Arztebl Int"},{"key":"3694_CR17","doi-asserted-by":"publisher","unstructured":"Mann NK, Mathes T, S\u00f6nnichsen A et\u00a0al (2023) Potenziell inad\u00e4quate Medikation f\u00fcr \u00e4ltere Menschen: PRISCUS 2.0. Dtsch \u00c4rztebl Int 120:3\u201310. https:\/\/doi.org\/10.3238\/arztebl.m2022.0377","DOI":"10.3238\/arztebl.m2022.0377"},{"issue":"5","key":"3694_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00063-018-0451-9","volume":"114","author":"K Hager","year":"2019","unstructured":"Hager\u00a0K, Temps\u00a0T, Krause\u00a0O (2019) Antidementiva. Antidepressiva und Neuroleptika bei alten Patienten absetzen : Wann m\u00f6glich, wann nicht? Med Klin Intensivmed Notfmed 114(5):463\u2013469. https:\/\/doi.org\/10.1007\/s00063-018-0451-9","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"3694_CR19","unstructured":"S3-Leitlinie \u201eDemenzen\u201c. (Langversion \u2013 Januar 2016). AWMF-Register-Nr.\u00a0038-013. https:\/\/register.awmf.org\/assets\/guidelines\/038-013l_S3-Demenzen-2016-07.pdf (letzter Zugriff 1. M\u00e4rz 2023)"},{"key":"3694_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007726.pub3","author":"E van Leeuwen","year":"2018","unstructured":"van Leeuwen\u00a0E, Petrovic\u00a0M, van Driel\u00a0ML et al (2018) Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007726.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"3694_CR21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00103-018-2796-x","volume":"61","author":"U Jaehde","year":"2018","unstructured":"Jaehde\u00a0U, Th\u00fcrmann\u00a0P (2018) Arzneimitteltherapiesicherheit bei Heimbewohnern. Bundesgesundheitsblatt 61:1111\u20131118. https:\/\/doi.org\/10.1007\/s00103-018-2796-x","journal-title":"Bundesgesundheitsblatt"},{"key":"3694_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.amjmed.2004.09.018","volume":"118","author":"JH Gurwitz","year":"2005","unstructured":"Gurwitz\u00a0JH, Field\u00a0TS, Judge\u00a0J et al (2005) The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 118:251\u2013258","journal-title":"Am J Med"},{"key":"3694_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2021-014280","author":"N Ayani","year":"2022","unstructured":"Ayani\u00a0N, Oya\u00a0N, Kitaoka\u00a0R et\u00a0al (2022) Epidemiology of adverse drug events and medication errors in four nursing homes in Japan: the Japan Adverse Drug Events (JADE) Study. BMJ Qual Saf. https:\/\/doi.org\/10.1136\/bmjqs-2021-014280","journal-title":"BMJ Qual Saf"},{"key":"3694_CR24","unstructured":"Hildebrandt JC (2015) Verf\u00fcgbarkeit und Relevanz von Laborwerten bei Arzneimitteltherapieentscheidungen im Altenheim. Dissertation, Universit\u00e4t Witten\/Herdecke."},{"key":"3694_CR25","unstructured":"Th\u00fcrmann P, Jaehde U (2011) Arzneimitteltherapiesicherheit in Alten- und Pflegeheimen: Querschnittsanalyse und Machbarkeit eines multidisziplin\u00e4ren Ansatzes. Abschlussbericht. https:\/\/www.bundesgesundheitsministerium.de\/service\/publikationen\/details\/arzneimitteltherapiesicherheit-in-alten-und-pflegeheimen-querschnittsanalyse-und-machbarkeit-eines-multidisziplinaeren-ansatzes.html. Zugegriffen: 17. Febr. 2023"},{"issue":"10","key":"3694_CR26","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.zefq.2012.10.021","volume":"106","author":"U Jaehde","year":"2012","unstructured":"Jaehde\u00a0U, Th\u00fcrmann\u00a0PA (2012) Arzneimitteltherapiesicherheit in Alten- und Pflegeheimen. Z\u00a0Evid Fortbild Qual Gesundhwes 106(10):712\u2013716. https:\/\/doi.org\/10.1016\/j.zefq.2012.10.021","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"3694_CR27","unstructured":"Th\u00fcrmann P, Jaehde U (2015) Arzneimitteltherapiesicherheit bei Patienten in Einrichtungen der Langzeitpflege (AMTS-AMPEL). Abschlussbericht. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/AMPELAbschlussbericht-gesamt-15-12-16.pdf. Zugegriffen: 17. Febr. 2023"},{"issue":"1","key":"3694_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12325-021-01939-9","volume":"39","author":"T Har\u0119\u017clak","year":"2022","unstructured":"Har\u0119\u017clak\u00a0T, Religioni\u00a0U, Szyma\u0144ski\u00a0FM et\u00a0al (2022) Drug interactions affecting kidney function: beware of health threats from triple whammy. Adv Ther 39(1):140\u2013147. https:\/\/doi.org\/10.1007\/s12325-021-01939-9","journal-title":"Adv Ther"},{"issue":"5","key":"3694_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00103-019-02927-9","volume":"62","author":"C Becker","year":"2019","unstructured":"Becker\u00a0C, Herrmann\u00a0A, Haefeli\u00a0WE, Rapp\u00a0K, Lindemann\u00a0U (2019) Neue Wege zur Pr\u00e4vention gesundheitlicher Risiken und der \u00dcbersterblichkeit von \u00e4lteren Menschen bei extremer Hitze. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 62(5):565\u2013570. https:\/\/doi.org\/10.1007\/s00103-019-02927-9","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3694_CR30","unstructured":"Universit\u00e4tsklinikum Heidelberg. Abteilung Klinische Pharmakologie und Pharmakoepidemiologie (2020) Hitzewellen. Pharmakologische Empfehlungen zur Risikominimierung bei Hitzewellen. https:\/\/dosing.de\/Hitze\/Medikamentenmanagement_bei_Hitzewellen.pdf. Zugegriffen: 17. Febr. 2023"},{"key":"3694_CR31","first-page":"522","volume-title":"Klinische Pharmazie","author":"I Waltering","year":"2017","unstructured":"Waltering\u00a0I, Hempel\u00a0G (2017) Medikationsmanagement bei Heimbewohnern. In: Jaehde\u00a0U, Radziwill\u00a0R, Kloft\u00a0C (Hrsg) Klinische Pharmazie, 4.\u00a0Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S\u00a0522\u2013529","edition":"4"},{"key":"3694_CR32","unstructured":"Leitliniengruppe Hessen https:\/\/register.awmf.org\/assets\/guidelines\/053-043l_S3_Multimedikation_2021-08.pdf. Zugegriffen: 17. Febr. 2023"},{"key":"3694_CR33","first-page":"131","volume-title":"Pflege-Report 2017 Die Versorgung der Pflegebed\u00fcrftigen","author":"A Schwinger","year":"2017","unstructured":"Schwinger\u00a0A, Tsiasioti\u00a0C, Klauber\u00a0J (2017) Herausforderndes Verhalten bei Demenz: Die Sicht der Pflege. In: Jacobs\u00a0K, Gre\u00df, Klauber, Schwinger (Hrsg) Pflege-Report 2017 Die Versorgung der Pflegebed\u00fcrftigen. Schattauer, Stuttgart, S 131\u2013148"},{"key":"3694_CR34","first-page":"119","volume-title":"Pflege-Report 2017 Die Versorgung der Pflegebed\u00fcrftigen","author":"P Th\u00fcrmann","year":"2017","unstructured":"Th\u00fcrmann\u00a0P (2017) Einsatz von Psychopharmaka bei Pflegebed\u00fcrftigen. In: Jacobs\u00a0K, Gre\u00df, Klauber, Schwinger (Hrsg) Pflege-Report 2017 Die Versorgung der Pflegebed\u00fcrftigen. Schattauer, Stuttgart, S 119\u2013128"},{"key":"3694_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/j.1532-2149.2011.00029.x","volume":"16","author":"M K\u00f6lzsch","year":"2012","unstructured":"K\u00f6lzsch\u00a0M, Wulff\u00a0I, Ellert\u00a0S, Fischer\u00a0T et al (2012) Deficits in pain treatment in nursing homes in Germany: a\u00a0cross-sectional study. Eur J Pain 16:439\u2013446","journal-title":"Eur J Pain"},{"key":"3694_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00391-012-0332-4","volume":"45","author":"I Wulff","year":"2012","unstructured":"Wulff\u00a0I, K\u00f6nner\u00a0F, K\u00f6lzsch\u00a0M, Budnick\u00a0A, Dr\u00e4ger\u00a0D, Kreutz\u00a0R (2012) Interdisziplin\u00e4re Handlungsempfehlung zum Management von Schmerzen bei \u00e4lteren Menschen in Pflegeheimen. Z\u00a0Gerontol Geriat 45:505\u2013544. https:\/\/doi.org\/10.1007\/s00391-012-0332-4","journal-title":"Z Gerontol Geriat"},{"key":"3694_CR37","unstructured":"Deutsches Netzwerk f\u00fcr Qualit\u00e4tsentwicklung in der Pflege (2020) Expertenstandard \u201eSchmerzmanagement in der Pflege \u2013 Aktualisierung 2020\u201c. Schriftenreihe des Deutschen Netzwerks f\u00fcr Qualit\u00e4tsentwicklung in der Pflege. Deutsches Netzwerk f\u00fcr Qualit\u00e4tsentwicklung in der Pflege, Osnabr\u00fcck. ISBN 978-3-00-065787\u20110"},{"issue":"2","key":"3694_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jpain.2015.10.016","volume":"17","author":"A Budnick","year":"2016","unstructured":"Budnick\u00a0A, Kuhnert\u00a0R, K\u00f6nner\u00a0F, Kalinowski\u00a0S, Kreutz\u00a0R, Dr\u00e4ger\u00a0D (2016) Validation of a\u00a0modified German version of the brief pain inventory for use in nursing home residents with chronic pain. J\u00a0Pain 17(2):248\u2013256. https:\/\/doi.org\/10.1016\/j.jpain.2015.10.016","journal-title":"J Pain"},{"issue":"3","key":"3694_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S1041610220000733","volume":"33","author":"D Wilfling","year":"2021","unstructured":"Wilfling\u00a0D, Hylla\u00a0J, Berg\u00a0A et\u00a0al (2021) Characteristics of multicomponent, nonpharmacological interventions to reduce or avoid sleep disturbances in nursing home residents: a\u00a0systematic review. Int Psychogeriatr 33(3):245\u2013273. https:\/\/doi.org\/10.1017\/S1041610220000733","journal-title":"Int Psychogeriatr"},{"key":"3694_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013339.pub2","author":"C Manietta","year":"2022","unstructured":"Manietta\u00a0C, Labont\u00e9\u00a0V, Thiesemann\u00a0R, Sirsch\u00a0EG, M\u00f6hler\u00a0R (2022) Algorithm-based pain management for people with dementia in nursing homes. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD013339.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"3694_CR41","first-page":"671","volume":"51","author":"G Glaeske","year":"2012","unstructured":"Glaeske\u00a0G, Schulze\u00a0J, Henke\u00a0F (2012) Polypharmazie im Alter. Mehr Sicherheit in der Arzneimitteltherapie. Schwest Pfleg 51(7):671\u2013676","journal-title":"Schwest Pfleg"},{"key":"3694_CR42","unstructured":"Koordinierungsgruppe Aktionsplan Arzneimitteltherapiesicherheit (2019) Ma\u00dfnahme 28: Workshop zur Umsetzung der in den bisherigen Forschungsprojekten des Aktionsplans AMTS gewonnen Erkenntnisse zur AMTS in Alten- und Pflegeheimen. https:\/\/www.akdae.de\/fileadmin\/user_upload\/akdae\/AMTS\/Aktionsplan\/Aktionsplan-2016-2020\/docs\/M28-WS-Ergebnisprotokoll.pdf. Zugegriffen: 1. M\u00e4rz 2023"},{"issue":"12","key":"3694_CR43","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1111\/bcp.14101","volume":"85","author":"SWH Lee","year":"2019","unstructured":"Lee\u00a0SWH, Mak\u00a0VSL, Tang\u00a0YW (2019) Pharmacist services in nursing homes: a systematic review and meta-analysis. Br J Clin Pharmacol 85(12):2668\u20132688. https:\/\/doi.org\/10.1111\/bcp.14101","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3694_CR44","doi-asserted-by":"publisher","first-page":"afac092","DOI":"10.1093\/ageing\/afac092","volume":"51","author":"EE Roughead","year":"2022","unstructured":"Roughead\u00a0EE, Pratt\u00a0NL, Parfitt\u00a0G et al (2022) Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a\u00a0multicentre, randomised controlled trial (the ReMInDAR trial). Age Ageing 51(4):afac92. https:\/\/doi.org\/10.1093\/ageing\/afac092","journal-title":"Age Ageing"},{"key":"3694_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009095.pub3","author":"DP Alldred","year":"2016","unstructured":"Alldred\u00a0DP, Kennedy\u00a0MC, Hughes\u00a0C, Chen\u00a0TF, Miller\u00a0P (2016) Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009095.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3694_CR46","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s41999-021-00477-5","volume":"12","author":"A Spinewine","year":"2021","unstructured":"Spinewine\u00a0A, Evrard\u00a0P, Hughes\u00a0C (2021) Interventions to optimize medication use in nursing homes: a\u00a0narrative review. Eur Geriatr Med 12(3):551\u2013567. https:\/\/doi.org\/10.1007\/s41999-021-00477-5","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"3694_CR47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12877-021-02287-7","volume":"21","author":"M Massot Mesquida","year":"2021","unstructured":"Massot Mesquida\u00a0M, Folkvord\u00a0F, Seda\u00a0G, Lupi\u00e1\u00f1ez-Villanueva\u00a0F, Tor\u00e1n Monserrat\u00a0P (2021) Cost-utility analysis of a\u00a0consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients. BMC Geriatr 21(1):327. https:\/\/doi.org\/10.1186\/s12877-021-02287-7","journal-title":"BMC Geriatr"},{"issue":"6","key":"3694_CR48","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.3390\/ijerph19063423","volume":"19","author":"N Molist-Brunet","year":"2022","unstructured":"Molist-Brunet N, Sevilla-S\u00e1nchez D, Puigoriol-Juvanteny E et al (2022) Individualized medication review in older people with Multimorbidity: a comparative analysis between patients living at home and in a nursing home. Int J Environ Res Public Health 19(6):3423. https:\/\/doi.org\/10.3390\/ijerph19063423","journal-title":"Int J Environ Res Public Health"},{"key":"3694_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008165.pub4","author":"A Rankin","year":"2018","unstructured":"Rankin\u00a0A, Cadogan\u00a0CA, Patterson\u00a0SM et\u00a0al (2018) Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008165.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3694_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/JCP.0000000000001521","volume":"42","author":"P St\u00f6tzner","year":"2022","unstructured":"St\u00f6tzner\u00a0P, Ferrebus Abate\u00a0RE, Henssler\u00a0J, Seethaler\u00a0M, Just\u00a0SA, Brandl\u00a0EJ (2022) Structured interventions to optimize polypharmacy in psychiatric treatment and nursing homes: a systematic review. J\u00a0Clin Psychopharmacol 42(2):169\u2013187. https:\/\/doi.org\/10.1097\/JCP.0000000000001521","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"3694_CR51","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40266-022-00978-3","volume":"39","author":"A Sadeq","year":"2022","unstructured":"Sadeq\u00a0A, Strugaru\u00a0M, Almutairi\u00a0M, Stewart\u00a0D, Ryan\u00a0C, Grimes\u00a0T (2022) Interprofessional interventions involving pharmacists and targeting the medicines management process provided to older people residing in nursing homes: a systematic review and meta-analysis of Randomised controlled trials. Drugs Aging 39(10):773\u2013794. https:\/\/doi.org\/10.1007\/s40266-022-00978-3","journal-title":"Drugs Aging"},{"issue":"8","key":"3694_CR52","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1089\/tmj.2021.0288","volume":"28","author":"C Berard","year":"2021","unstructured":"Berard\u00a0C, Di Mascio\u00a0T, Montaleytang\u00a0M et\u00a0al (2021) Telemedication reviews to optimize medication prescription for older people in nursing homes. Telemed J E Health 28(8):1225\u20131232. https:\/\/doi.org\/10.1089\/tmj.2021.0288","journal-title":"Telemed J E Health"},{"key":"3694_CR53","doi-asserted-by":"publisher","first-page":"104471","DOI":"10.1016\/j.ijmedinf.2021.104471","volume":"151","author":"R Dendere","year":"2021","unstructured":"Dendere\u00a0R, Samadbeik\u00a0M, Janda\u00a0M (2021) The impact on health outcomes of implementing electronic health records to support the care of older people in residential aged care: A scoping review. Int J Med Inform 151:104471. https:\/\/doi.org\/10.1016\/j.ijmedinf.2021.104471","journal-title":"Int J Med Inform"},{"key":"3694_CR54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1197\/jamia.M2981","volume":"16","author":"TS Field","year":"2009","unstructured":"Field\u00a0TS, Rochon\u00a0P, Lee\u00a0M, Gavendo\u00a0L, Baril\u00a0JL, Gurwitz\u00a0JH (2009) Computerized clinical decision support during medication ordering for long-term care residents with renal insufficiency. J\u00a0Am Med Inform Assoc 16:480\u2013485","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"3694_CR55","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1186\/s12913-022-08378-4","volume":"22","author":"R Moecker","year":"2022","unstructured":"Moecker\u00a0R, Weissenborn\u00a0M, Klingenberg\u00a0A et\u00a0al (2022) Task sharing in an interprofessional medication management program\u2014a\u00a0survey of general practitioners and community pharmacists. BMC Health Serv Res 22(1):1005. https:\/\/doi.org\/10.1186\/s12913-022-08378-4","journal-title":"BMC Health Serv Res"},{"key":"3694_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12877-019-1052-z","volume":"19","author":"K Bitter","year":"2019","unstructured":"Bitter\u00a0K, Pehe\u00a0C, Kr\u00fcger\u00a0M, Heuer\u00a0G, Quinke\u00a0R, Jaehde\u00a0U (2019) Pharmacist-led medication reviews for geriatric residents in German long-term care facilities. BMC Geriatr 19:39","journal-title":"BMC Geriatr"},{"issue":"1","key":"3694_CR57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12877-019-1027-0","volume":"19","author":"O Krause","year":"2019","unstructured":"Krause\u00a0O, Wiese\u00a0B, Doyle\u00a0IM et al (2019) Multidisciplinary intervention to improve medication safety in nursing home residents: protocol of a\u00a0cluster randomised controlled trial (HIOPP-3-iTBX study). BMC Geriatr 19(1):24. https:\/\/doi.org\/10.1186\/s12877-019-1027-0","journal-title":"BMC Geriatr"},{"key":"3694_CR58","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3238\/arztebl.m2021.0297","volume":"118","author":"U Junius-Walker","year":"2021","unstructured":"the HIOPP-3-iTBX study group, Junius-Walker\u00a0U, Krause\u00a0O, Th\u00fcrmann\u00a0P et al (2021) Drug safety for nursing-home residents\u2014findings of a\u00a0pragmatic, cluster-randomized, controlled intervention trial in 44 nursing homes. Dtsch Arztebl Int 118:705\u2013712. https:\/\/doi.org\/10.3238\/arztebl.m2021.0297","journal-title":"Dtsch Arztebl Int"},{"key":"3694_CR59","first-page":"4014","volume":"162","author":"J Hildebrand","year":"2022","unstructured":"Hildebrand\u00a0J (2022) Fehler im Medikationsprozess kann man nur vermeiden, wenn man sie erkennt: Erster Masterstudiengang zu AMTS gestartet. Dtsch Apoth\u00a0Z 162:4014\u20134016","journal-title":"Dtsch Apoth Z"},{"key":"3694_CR60","unstructured":"https:\/\/www.amts-ampel.de\/fileadmin\/img\/downloads\/AMTS-Karte_final.pdf;. Zugegriffen: 17. Febr. 2023"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-023-03694-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-023-03694-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-023-03694-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:04:06Z","timestamp":1683281046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-023-03694-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["3694"],"URL":"https:\/\/doi.org\/10.1007\/s00103-023-03694-4","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"4 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.A.\u00a0Th\u00fcrmann, S.\u00a0Bergner und U.\u00a0Jaehde geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}